The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance : Correlation with replicative bypass of platinum-DNA adductsVAISMAN, A; VARCHENKO, M; UMAR, A et al.Cancer research (Baltimore). 1998, Vol 58, Num 16, pp 3579-3585, issn 0008-5472Article

Histoire naturelle des adénocarcinomes ovariens : de l'épidémiologie à l'expérimentation = Natural history of epithelial ovarian cancer : from epidemiology to experimentationHAMILTON, T. C; PENAULT-LLORCA, F; DAUPLAT, J et al.Contraception, fertilité, sexualité (1991). 1998, Vol 26, Num 11, pp 800-804, issn 1157-8181Article

Molecular biology of gynecologic malignanciesHAMILTON, T. C; JOHNSON, S. W; GODWIN, A. K et al.Cancer treatment and research. 1998, Vol 95, pp 103-114, issn 0927-3042Article

Comparison of the cardiovascular effects of the novel 5-HT_1B/1D receptor agonist, SB 209509 (VML251), and sumatriptan in dogsPARSONS, A. A; PARKER, S. G; RAVAL, P et al.Journal of cardiovascular pharmacology. 1997, Vol 30, Num 1, pp 136-141, issn 0160-2446Article

Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cellsABDOLLAHI, A; GODWIN, A. K; MILLER, P. D et al.Cancer research (Baltimore). 1997, Vol 57, Num 10, pp 2029-2034, issn 0008-5472Article

Time-dependent pharmacodynamic models in cancer chemotherapy : population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a phase I trial of melphalan and BSOGALLO, J. M; BRENNAN, J; HAMILTON, T. C et al.Cancer research (Baltimore). 1995, Vol 55, Num 20, pp 4507-4511, issn 0008-5472Article

Transformation of rat ovarian epithelial and rat-1 fibroblast cell lines by RAST24 does not influence cisplatin sensitivityPEREZ, R. P; HAMAGUCHI, K; TRACEY, P. A et al.Cancer research (Baltimore). 1993, Vol 53, Num 16, pp 3771-3775, issn 0008-5472Article

Metallothionein gene expression and resistance to cisplatin in human ovarian cancerSCHILDER, R. J; HALL, L; MONKS, A et al.International journal of cancer. 1990, Vol 45, Num 3, pp 416-422, issn 0020-7136Article

Enhanced DNA repair and resistance to cisplatin in human ovarian cancerGI-MING LAI; OZOLS, R. F; SMYTH, J. F et al.Biochemical pharmacology. 1988, Vol 37, Num 24, pp 4597-4600, issn 0006-2952Article

Genes amplified and overexpressed in human multidrug-resistant cell linesVAN DER BLIEK, A. M; BAAS, F; VAN DER VELDE-KOERTS, T et al.Cancer research (Baltimore). 1988, Vol 48, Num 21, pp 5927-5932, issn 0008-5472Article

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionHAMILTON, T. C; WINKER, M. A; LOUIE, K. G et al.Biochemical pharmacology. 1985, Vol 34, Num 14, pp 2583-2586, issn 0006-2952Article

Studies of androgen and estrogen binding in normal canine prostatic tissue and in epithelial and stromal cell lines derived from the canine prostateEATON, C. L; HAMILTON, T. C; KENVYN, K et al.The Prostate. 1985, Vol 7, Num 4, pp 377-388, issn 0270-4137Article

Effects of talc on the rat ovaryHAMILTON, T. C; FOX, H; BUCKLEY, C. H et al.British journal of experimental pathology. 1984, Vol 65, Num 1, pp 101-106, issn 0007-1021Article

Synthesis and antihypertensive activity of substituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-olsEVANS, J. M; FAKE, C. S; HAMILTON, T. C et al.Journal of medicinal chemistry (Print). 1983, Vol 26, Num 11, pp 1582-1589, issn 0022-2623Article

Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cellsABDOLLAHI, A; GETTS, L. A; SONODA, G et al.Journal of the Society for Gynecologic Investigation. 1999, Vol 6, Num 1, pp 32-40, issn 1071-5576Article

Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxelOBASAJU, C. K; JOHNSON, S. W; ROGATKO, A et al.Clinical cancer research. 1996, Vol 2, Num 3, pp 549-552, issn 1078-0432Article

Identification of two candidate tumor suppressor genes on chromosome 17p13.3SCHULTZ, D. C; VANDERVEER, L; BERMAN, D. B et al.Cancer research (Baltimore). 1996, Vol 56, Num 9, pp 1997-2002, issn 0008-5472Article

Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell linesO'DWYER, P. J; PEREZ, R. P; YAO, K.-S et al.Biochemical pharmacology. 1996, Vol 52, Num 1, pp 21-28, issn 0006-2952, 7 p.Article

Motor dysfunction in a photothrombotic focal ischaemia modelWOOD, N. I; SOPESEN, B. V; ROBERTS, J. C et al.Behavioural brain research. 1996, Vol 78, Num 2, pp 113-120, issn 0166-4328Article

Determinants of cisplatin sensitivity in normal versus spontaneously transformed rat ovarian surface epithelial cellsPEREZ, R. P; JOHNSON, S. W; HANDEL, L. M et al.Gynecologic oncology (Print). 1995, Vol 58, Num 3, pp 312-318, issn 0090-8258Conference Paper

Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexityTESTA, J. R; GETTS, L. A; SALAZAR, H et al.Cancer research (Baltimore). 1994, Vol 54, Num 10, pp 2778-2784, issn 0008-5472Article

Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell linesHAMAGUCHI, K; GODWIN, A. K; YAKUSHIJI, M et al.Cancer research (Baltimore). 1993, Vol 53, Num 21, pp 5225-5232, issn 0008-5472Article

Clinical reversal of drug resistance in ovarian cancerOZOLS, R. F; O'DWYER, P. J; HAMILTON, T. C et al.Gynecologic oncology (Print). 1993, Vol 51, Num 1, pp 90-96, issn 0090-8258Conference Paper

Mechanisms of drug resistance in ovarian cancerJOHNSON, S. W; OZOLS, R. F; HAMILTON, T. C et al.Cancer. 1993, Vol 71, Num 2, pp 644-649, issn 0008-543X, SUPConference Paper

In vitro interactions between platinum analogues in human ovarian-carcinoma cell linesPEREZ, R. P; PEREZ, K. M; HANDEL, L. M et al.Cancer chemotherapy and pharmacology. 1992, Vol 29, Num 6, pp 430-434, issn 0344-5704Article